Concepedia

Correlation between Androgen Receptor Expression and Immunohistochemistry Type as Prognostic Factors in a Cohort of Breast Cancer Patients: Result from a Single-Center, Cross Sectional Study

Irina Niță, Cornelia Niţipir, Ştefania Andreea Toma, Alexandra Maria Limbău, Edvina Elena Pîrvu, Ioana Anca Bădărău, Ioana Suciu, George Suciu, Loredana Sabina Cornelia Manolescu

Healthcare · 2021 · 22 citations · 40 references

DOIFull text

Open access

Abstract

Both OS and PFS were favorably influenced by the presence of AR. TNBC had worse outcomes compared with patients with hormonal or/and Her 2/neu positive disease in terms of OS.

References

40

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

Antonio C. Wolff, M. Elizabeth Hammond, David G. Hicks et al. · Journal of Clinical Oncology · 2013 · 4K citations · Full text

3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

Fátima Cardoso, A. Costa, Elżbieta Senkus et al. · Annals of Oncology · 2016 · 2.1K citations · Full text

4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)

Fátima Cardoso, Elżbieta Senkus, A. Costa et al. · Annals of Oncology · 2018 · 1.1K citations · Full text

Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State

Betsy Kohler, Recinda Sherman, Nadia Howlader et al. · JNCI Journal of the National Cancer Institute · 2015 · 915 citations · Full text

Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis

Hajime Uno, Brian Claggett, Lü Tian et al. · Journal of Clinical Oncology · 2014 · 721 citations · Full text

, , +15